1. United States of America Stocks

  2. •

    Technology

  3. •

    Software - Application
Enfusion, Inc.

Enfusion, Inc.

ENFN
Enfusion, Inc.US flagNew York Stock Exchange
10.76
USD
-0.04
- -
1.02BMarket Cap

Total Valuation

Enfusion, Inc. carries a market capitalization of 1.02B, placing it among publicly traded companies globally. Its enterprise value stands at 940.15M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.02B
Enterprise Value940.15M

Share Statistics

Enfusion, Inc. currently has 94.77M shares outstanding.

Shares Outstanding94.77M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Enfusion, Inc. trades at a trailing price-to-earnings ratio of 335.81. The price-to-sales ratio is 4.70, and the price-to-book ratio stands at -5.58.

PE Ratio335.81
PS Ratio4.70
PB Ratio-5.58
P/TBV Ratio9.52
P/FCF Ratio32.05
P/OCF Ratio27.33

Enterprise Valuation

On an enterprise value basis, Enfusion, Inc. trades at an EV/EBITDA multiple of 52.50 and an EV/FCF ratio of 24.54. The EV/Sales ratio of 4.66 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 152.75 provides insight into valuation relative to core operating earnings.

EV / Sales4.66
EV / EBITDA52.50
EV / EBIT152.75
EV / FCF24.54

Financial Position

Enfusion, Inc. maintains a current ratio of 3.42, meaning it holds 3.4x the short-term assets needed to cover near-term liabilities.

Current Ratio3.42
Quick Ratio3.16
Debt / Equity20.41
Debt / EBITDA1.13
Interest CoverageN/A

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)2.24
Return on Invested Capital (ROIC)3.05
Return on Capital Employed (ROCE)-1.35
Revenue Per EmployeeN/A
Employee CountN/A
Inventory TurnoverN/A

Taxes

Over the trailing twelve months, Enfusion, Inc. has paid 3.47M in income taxes, reflecting an effective tax rate of 47.02.

Income Tax3.47M
Effective Tax Rate47.02

Stock Price Statistics

Enfusion, Inc.'s stock has gained approximately 11.27198% over the past 52 weeks. The 50-day moving average sits at 11.09, while the 200-day moving average is 9.90.

Beta (5Y)N/A
52-Week Price Change11.27198%
50-Day Moving Average11.09
200-Day Moving Average9.90
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Enfusion, Inc. generated 201.61M in revenue and converted that into 2.82M in net income, yielding earnings per share of 0.03. EBITDA reached 17.91M, while operating income came in at 6.16M.

Revenue201.61M
Gross Profit136.74M
Operating Income6.16M
Pretax Income7.39M
Net Income2.82M
EBITDA17.91M
EBIT6.16M
Earnings Per Share (EPS)0.03

Balance Sheet

Enfusion, Inc. holds 54.48M in cash and equivalents against 20.31M in total debt, resulting in a net debt position of -54.48M. Total book value stands at -169.98M, with working capital of 66.19M providing operational flexibility.

Cash & Cash Equivalents54.48M
Total Debt20.31M
Net Debt-54.48M
Equity (Book Value)-169.98M
Book Value Per Share-1.85
Working Capital66.19M

Cash Flow

Enfusion, Inc. produced 34.68M in operating cash flow over the past twelve months. After subtracting -3.63M in capital expenditures, free cash flow totaled 31.05M - equivalent to 0.34 per share.

Operating Cash Flow34.68M
Capital Expenditures-3.63M
Free Cash Flow31.05M
FCF Per Share0.34

Margins

Enfusion, Inc. operates with a gross margin of 67.82, reflecting its pricing power and cost economics. The operating margin of 3.05 and net profit margin of 1.40 provide insight into operational efficiency.

Gross Margin67.82
Operating Margin3.05
Pretax Margin3.66
Profit Margin1.40
EBITDA Margin8.88

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield0.15
FCF Yield3.12

Scores

Enfusion, Inc. posts an Altman Z-Score of 13.45, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score13.45